Search

Your search keyword '"Bagot, Martine"' showing total 1,838 results

Search Constraints

Start Over You searched for: Author "Bagot, Martine" Remove constraint Author: "Bagot, Martine"
1,838 results on '"Bagot, Martine"'

Search Results

2. Radiotherapy in cutaneous lymphomas: Recommendations from the EORTC cutaneous lymphoma tumour group

3. Real-life efficacy of immunotherapy for Sézary syndrome: a multicenter observational cohort study

4. Coencapsulation of Immunosuppressive Drug with Anti-Inflammatory Molecule in Pickering Emulsions as an Innovative Therapeutic Approach for Inflammatory Dermatoses

5. Approach to Mycosis Fungoides in children: Consensus-based recommendations

7. EORTC consensus recommendations for the treatment of mycosis fungoides/Sézary syndrome – Update 2023

10. Allogeneic transplantation in advanced cutaneous T-cell lymphomas (CUTALLO): a propensity score matched controlled prospective study

12. Primary cutaneous lymphoma: recommendations for clinical trial design and staging update from the ISCL, USCLC, and EORTC

13. Macrophage-derived CXCL9 and CXCL11, T-cell skin homing, and disease control in mogamulizumab-treated CTCL patients

14. Real-world study of pegylated interferon α-2a to treat mycosis fungoides/Sézary syndrome using time to next treatment as a measure of clinical benefit: an EORTC CLTG study.

15. Emergence of Difficult-to-Treat Tinea Corporis Caused by Trichophyton mentagrophytes Complex Isolates, Paris, France

18. Evolution of patients with Sézary syndrome after mogamulizumab discontinuation for any cause except progression: a multicenter retrospective study (Moga-stop study)

19. Real-world study on the use of pegylated interferon alpha-2a for treatment of mycosis fungoides/Sézary syndrome using Time to Next Treatment as a measure of clinical benefit: An EORTC CLTG study

20. Impact of blood tumour clone frequency on time to next treatment in mycosis fungoides

21. Targeting TGF-beta activation in cutaneous T-cell lymphomas

23. “Co-encapsulation of Immunosuppressive Drug with Anti-inflammatory Molecule in Pickering Emulsions as a Novel Therapeutic Approach for Inflammatory Dermatoses”

30. Consensus statement on the diagnosis and treatment of sclerosing diseases of the skin, Part 2: Scleromyxoedema and scleroedema.

32. Two cases of dupilumab-responsive Kimura disease.

33. ICOS is widely expressed in cutaneous T-cell lymphoma, and its targeting promotes potent killing of malignant cells

36. Resminostat for Maintenance Treatment in Patients with Advanced Stage Mycosis Fungoides or Sézary Syndrome: A Multicentre, Double-Blind, Randomised, Placebo-Controlled, Phase 2 Trial

37. Two cases of Dupilumab responsive Kimura disease

41. IPH4102, a first-in-class anti-KIR3DL2 monoclonal antibody, in patients with relapsed or refractory cutaneous T-cell lymphoma: an international, first-in-human, open-label, phase 1 trial

42. Large International Validation of ABSIS and PDAI Pemphigus Severity Scores

43. A Retrospective Chart Review of Treatment Patterns and Overall Survival among a Cohort of Patients with Relapsed/Refractory Mycosis Fungoides in France, Germany, Italy, Spain and the United Kingdom

44. Cutaneous manifestations of lymphoid‐variant hypereosinophilic syndrome

45. Skin involvement in systemic lymphoma of follicular helper T-cell origin: a cohort study of 57 patients

46. Lacutamab in patients with mycosis fungoides: efficacy results according to updated lymph node classification in the TELLOMAK study

47. Primary cutaneous follicle center lymphoma with secondary systemic evolution

48. ISCL/USCLC/EORTC guidelines for the diagnosis, staging, and treatment of pediatric mycosis fungoides

49. CD38 targeting in aggressive, treatment-refractory cutaneous T-cell lymphomas

50. Evaluating Response Trends of Chlormethine/Mechlorethamine Gel in Patients With Stage I-IIA Mycosis Fungoides: Analysis of Individual Patient Data From a Randomized Controlled Phase II Study to Facilitate Optimal Treatment Experiences

Catalog

Books, media, physical & digital resources